Flexion Therapeutics Enrolls First Patient in Pharmacokinetic Study of Zilretta™ for Osteoarthritis of the Knee

By: via Benzinga
Flexion Therapeutics, Inc. (Nasdaq: FLXN) announced today that it has enrolled its first patient in a pharmacokinetic (PK) study of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.